You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to October 2023

AbstractFullPdf
Nov 2022229015
Dec 202211206
Jan 20238602
Feb 20239803
Mar 20238002
Apr 20237002
May 202376010
Jun 20235602
Jul 20238807
Aug 20236802
Sep 20237203
Oct 20237202
Total1107056